HTA Alerts - Med Tech

Subscription service with email alerts about initiated, published and ongoing health technology assessments of medical devices and in-vitro diagnostic tests from 68 HTA organizations globally

Get three-month, free, no-obligation trial to understand the value of the service to your organization

Request a quote and arrange a free trial

This sub-site (services.mtrconsult.com) is no longer updated. Please, proceed to our main web-site to learn about our services (www.mtrconsult.com)

Health technology assessment (HTA) is a multidisciplinary process that summarizes information about the medical, social, economic and ethical issues related to the use of medical technologies in a systematic, transparent, unbiased, and robust manner.

The key objective of HTA is to advise policymakers and providers about the necessity of adopting and appropriateness of reimbursing procedures, devices, and IVD tests.

Most developed countries have functioning HTA frameworks on different levels (national, regional, and hospital-based). Only in Europe 337 and 256 Med Tech HTA reports were released in 2018 and 2019, respectively.

HTA plays an important role in the market access landscape for medical technologies. Very often, HTA is a formal part of the reimbursement or funding processes (e.g., in France or Norway), or it is not formally connected to the reimbursement process, but it significantly impacts the adoption of technologies (e.g., in England).

Market access professionals closely monitor initiated and published HTAs for the products under their supervision. The key challenges for effective monitoring are the large number of HTA organizations, language barriers, and lack of time to do such monitoring properly.

MTRC offers a unique service of monitoring developments with initiated or published HTA reports for medical technologies globally, so that you do not miss any single HTA for your technology.

This is a twin service with similar activity on key reimbursement news for medical devices (procedure coding, DRG and reimbursement codes, coverage decisions, clinical guidelines developed by governmental organizations) in 15 European countries, "Reimbursement Alerts – Med Tech".

Key features of the service

More than 500 HTA reports (published, initiated, ongoing) are detected every 2 weeks globally (about 300 - in Europe)

Global coverage
The service includes key HTA organizations in Europe and globally (Argentina, Australia, Brazil, Canada, Chile, Colombia, Japan, Malaysia, Mexico, Peru, Singapore, South Africa, South Korea, Taiwan, Thailand, UAE and the USA). In total, 68 active HTA organizations from 36 countries producing Med Tech-related HTA reports are included
All reports are classified according to 31 Technology Groups
The service helps to focus only on technologies of interest (e.g., cardiovascular or neuromodulating devices) and avoid wasting time on not relevant reports
All types of HTA organizations are included
The service includes international (e.g., EUnetHTA), national and regional HTAs. The service includes 68 organizations. Organizations were selected on the basis of an audit of their activity
Customized alerts and unlimited number of subscribers
All reports are customized based on the client's preferences about geographical (you can select only particular countries for monitoring) and technological (e.g., only news for neuromodulation technologies) coverage. The number of enrolled subscribers from one company is unlimited
Timely alerts with essential information in English
Alerts about initiated or published HTAs are sent to email every 2 weeks. For each report, a title, brief summary in English (if available) and the link are provided. You can follow the link to investigate the report further. Every new newsletter covers the last two weeks
Reports are developed using a manual search
We do not trust search robots to identify and classify relevant information. The search and categorization of identified reports is performed manually by MTRC analysts
Both general and technology-specific news are included
The service captures both general (e.g., new program at NICE, or termination of work of Swiss Medical Board) and technology-specific (e.g., new HTA for transcatheter aortic valve implantation) news

Why use "HTA Alerts"?

Timely access to essential information
You can be the first to know about important developments for technology within the company and with your competition. New HTA reports reveal new opportunities for your company's business
Ability to engage with HTA stakeholders
By knowing about initiated assessment, you can engage with HTA bodies in a timely manner to provide relevant information about your technology to increase chances of more unbiased assessment and positive result of HTA
Cost-effective approach
No single Med Tech company can afford such a massive screening and monitoring activity. You outsource an essential function of keeping the company up-to-date at a modest cost. You can save both time and money with an external HTA monitoring service. Both quarterly and annual payments are possible
Customized information in a user-friendly format
You only get access to HTA information for countries (e.g., EMEA only) and technologies (e.g., peripheral vascular) of relevance to your position. Newsletters are easy to navigate and easy to distribute internally
Suitable for both middle-size companies and large corporations
The service is suitable for both middle-size companies with 1-2 people in the market access function and large corporations. For small companies, the service is the only opportunity to keep track of significant developments, and for large corporations, it complements the internal effort
More professional fulfillment of the market access role
Market access professionals use all modern tools at their disposal to execute their function professionally. "HTA Alerts" is becoming a new industry standard and essential tool in the portfolio of market access specialists

A service from a well-known partner

40%

of top-30 Med Tech companies trust MTRC subscription services

154 clients

received support from MTRC over the last three years

19 countries

where MTRC provides regular consulting services

700+ projects

were accomplished since 2017

About MTRC

A specialized Med Tech reimbursement consultancy

17 out of top-30 global Med Tech companies routinely use reimbursement services of MTRC

Coverage of 19 European markets with consulting services

>130 reimbursement projects per year

15 full-time employees, located in six European countries. In-house coverage of key languages (French, German, Italian, Spanish, Polish, Russian, Turkish)

ISO 9001:2015 certified with the United Kingdom Accreditation Service, UKAS

Main web-sites: Med Tech, Online school in market access